1. Abramsky, O. and Litvin, Z.J. (1978) Autoimmune response to dopamine-receptor as a possible mechanism in the pathogenesis of Parkinson's disease and schizophrenia. Prospect. Biol. Med. 22, 104–114.
2. Alonso, R., Chaudieu, I., Diorio, J., Krishnamurthy, A., Quirion, R. and Boksa, P. (1993) Interleukin-2 modulates evoked release of [3H]dopamine in rat cultured mesencephalic cells. J. Neurochem. 61, 1284–1290.
3. Araujo, D.M., Lapchak, P.A., Chabot, J.G., Nair, N.P. and Quirion, R. (1989a) Characteristics and possible role of growth factor and lymphokine receptors in the regulation of cholinergic function in the mammalian brain. Prog. Clin. Biol. Res. 317, 423–436.
4. Araujo, D.M., Lapchak, P.A. Collier, B. and Quirion, R. (1989b) Localization of interleukin-2 immunoreactivity and interleukin-2 receptors in the rat brain: Interaction with the cholinergic system. Brain Res. 498, 257–266.
5. Banks, W.A. and Kastin, A.J. (1992) The interleukins-1α, -1β and -2 do not acutely disrupt the murine blood–brain barrier. Int. J. Immunopharmacol. 4, 629–636.